Our research group is interested in the molecular mechanisms defining the transcriptomics and epigenomic states of oligodendrocyte lineage cells in the central nervous system, in the context of neuroinflammatory and demyelinating diseases, such as multiple sclerosis. To implement this scientific approach, we apply state-of-the-art technologies, including single-cell and spatial transcriptomics and epigenomics, and CRISPR-based screens, in rodent models of disease and human patient material.

Group Members

Tony Jimenez-Beristain
Eneritz Agirre
Bastien Hervé
Özge Dumral
Yuk Kit Charles Lor
Fleur de Boer
Carmen Abaurre
Yonglong Dang
Leslie Kirby
Neemat Mahmud
Christoffer Mattsson Langseth
Clemens Ries
Ting Sun
Mattia Zaghi
Karl Carlström